Tag: SGLT2 inhibitors

KDIGO guideline for diabetic CKD patient treatment updated

The Kidney Disease: Improving Global Outcomes (KDIGO) Work Group has issued a 2022 update to its 2020 guideline for the management of diabetes in...

SGLT2 inhibitors demonstrate efficacy and safety in diabetic kidney transplant recipients

Sodium-glucose cotransporter-2 (SGLT2) inhibitors can be used safely to help preserve graft function in diabetic kidney transplant recipients, as per the findings from a...